Aeon Biopharma Inc (AEON)

Currency in USD
0.75
-0.01(-0.94%)
Real-time Data·
AEON Scorecard
Full Analysis
Quickly burning through cash
AEON is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.720.76
52 wk Range
0.38115.57
Key Statistics
Prev. Close
0.76
Open
0.76
Day's Range
0.72-0.76
52 wk Range
0.38-115.57
Volume
31.32K
Average Volume (3m)
732.68K
1-Year Change
-98.97%
Book Value / Share
-1.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AEON Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.20
Upside
+860.00%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Aeon Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Aeon Biopharma Inc Company Profile

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.

Compare AEON to Peers and Sector

Metrics to compare
AEON
Peers
Sector
Relationship
P/E Ratio
−5.3x−3.1x−0.6x
PEG Ratio
−0.060.030.00
Price/Book
−0.6x2.3x2.6x
Price / LTM Sales
-8.9x3.3x
Upside (Analyst Target)
-201.5%39.1%
Fair Value Upside
Unlock5.7%4.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.20
(+860.00% Upside)

Earnings

Latest Release
Aug 12, 2025
EPS / Forecast
-0.60 / -0.31
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

AEON Income Statement

People Also Watch

20.66
SRPT
-1.57%
3.8200
CLDI
-6.83%
5.29
REPL
-0.75%
49.11
BMNR
-10.50%
2.42
INMB
-4.15%

FAQ

What Stock Exchange Does Aeon Biopharma Trade On?

Aeon Biopharma is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Aeon Biopharma?

The stock symbol for Aeon Biopharma is "AEON."

What Is the Aeon Biopharma Market Cap?

As of today, Aeon Biopharma market cap is 8.94M.

What Is Aeon Biopharma's Earnings Per Share (TTM)?

The Aeon Biopharma EPS (TTM) is -0.40.

From a Technical Analysis Perspective, Is AEON a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Aeon Biopharma Stock Split?

Aeon Biopharma has split 1 times.

How Many Employees Does Aeon Biopharma Have?

Aeon Biopharma has 5 employees.

What is the current trading status of Aeon Biopharma (AEON)?

As of 19 Aug 2025, Aeon Biopharma (AEON) is trading at a price of 0.75, with a previous close of 0.76. The stock has fluctuated within a day range of 0.72 to 0.76, while its 52-week range spans from 0.38 to 115.57.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.